Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
Dyno Therapeutics
Dyno Therapeutics
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
Dyno Therapeutics
Total Funding
$109 M
Dyno Therapeutics Summary
Company Summary
Overview
Dyno Therapeutics is a biotechnology company that provides AI-powered gene therapies. It develops CapsidMap, a platform that uses AI to optimize adeno-associated virus (AAV) capsid vectors for the treatment of skeletal and cardiac muscle diseases.
Type
Private
Status
Active
Founded
2018
HQ
Watertown, MA, US
|
view all locations
Website
https://www.dynotx.com
Cybersecurity rating
Sectors
Healthcare
artificial intelligence
biotech
genetics
healthtech
medical diagnostics
platform
therapy
Homepage
Linkedin
twitter
Table of Contents
Key People
Locations
Competitors
News
Key People
Eric Kelsic,
CEO & Co-Founder, Director
Linkedin
Alan Crane,
Executive Chairman
Sam Sinai,
Co-Founder & Head of Computation
Linkedin
Adrian Veres,
CSO & Co-Founder
Linkedin
and 10 others
Locations
View all
1 location detected
Watertown, MA
HQ
United States
343 Arsenal Street, Suite 101
Report incorrect company information
Competitors and Similar Companies
Oxford BioTherapeutics
Healthcare - Private
Orchard Therapeutics
Healthcare - Public
Stealth BioTherapeutics
Healthcare - Public
BigHat Biosciences
Healthcare - Private
Compare competitors
News
Dyno Therapeutics Closes $100 Million Series A Financing, 59% OFF
Jan 26, 2024
Dyno Therapeutics Raises $9M in Seed Financing
May 11, 2020
Report incorrect company information
Footer menu
Contact us
Facebook
Twitter
LinkedIn
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2024
Share price data provided by IEX
Back
to top